| dc.contributor.author | Valenzuela-Méndez, Blanca | |
| dc.contributor.author | Valenzuela-Sánchez, Francisco | |
| dc.contributor.author | Rodríguez‑Gutiérrez, Juan Francisco | |
| dc.contributor.author | Bohollo-de-Austria, Rafael | |
| dc.contributor.author | Estella García, Ángel | |
| dc.contributor.author | Martínez-García, Pilar | |
| dc.contributor.author | González-García, María Ángela | |
| dc.contributor.author | Rello, Jordi | |
| dc.contributor.other | Medicina | es_ES |
| dc.date.accessioned | 2022-04-04T06:46:04Z | |
| dc.date.available | 2022-04-04T06:46:04Z | |
| dc.date.issued | 2022-01 | |
| dc.identifier.issn | 2075-4426 | |
| dc.identifier.uri | http://hdl.handle.net/10498/26547 | |
| dc.description.abstract | Early identification of severe viral pneumonia in influenza virus A (H1N1pdm09) patients is extremely important for prompt admission to the ICU. The objective is to evaluate the usefulness of MR-proadrenomedullin (MR-proADM) compared to C reactive protein (CRP), procalcitonin (PCT), and ferritin in the prognosis of influenza A pneumonia. This prospective, observational, multicenter study included one hundred thirteen patients with confirmed influenza virus A (H1N1pdm09) admitted to an Emergency Department and ICUs of six hospitals in Spain. Measurements and Main Results: one-hundred thirteen patients with confirmed influenza virus A (H1N1pdm09) were enrolled. Seventy-five subjects (mortality 29.3%) with severe pneumonia caused by influenza A H1N1pdm09 virus (H1N1vIPN) were compared with 38 controls (CG).The median MR-proADM levels at hospital admission were 1.2 nmol/L (IQR (0.8-2.6) vs. 0.5 nmol/L (IQR 0.2-0.9) in the CG (p = 0.01), and PCT levels were 0.43 mu g/L (IQR 0.2-1.2) in the H1N1vIPN group and 0.1 mu g/L (IQR 0.1-0.2) in the CG (p < 0.01). CRP levels at admission were 15.5 mg/dL(IQR 9.2-24.9) in H1N1vIPN and 8.6 mg/dL(IQR 3-17.3) in the CG (p < 0.01). Ferritin levels at admission were 558.1 ng/mL(IQR 180-1880) in H1N1vIPN and 167.7 ng/mL(IQR 34.8-292.9) in the CG (p < 0.01). A breakpoint for hospital admission of MR-proADM of 1.1 nmol/L showed a sensitivity of 55% and a specificity of 90% (AUC-ROC0.822). Non-survivors showed higher MR-proADM levels: median of 2.5 nmol/L vs. 0.9 nmol/L among survivors (p < 0.01). PCT, CRP, and ferritin levels also showed significant differences in predicting mortality. The MR-proADM AUC-ROC for mortality was 0.853 (p < 0.01). In a Cox proportional hazards model, MR-proADM levels > 1.2 nmol/L at hospital admission were significant predictive factors for ICU and 90-day mortality (HR: 1.3). Conclusions: the initial MR-proADM, ferritin, CRP, and PCT levels effectively determine adverse outcomes and risk of ICU admission and mortality in patients with influenza virus pneumonia. MR-proADM has the highest potency for survival prediction. | es_ES |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | MDPI | es_ES |
| dc.rights | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.source | J. Pers. Med. 2022, 12(1), 84 | es_ES |
| dc.subject | H1N1 influenza pneumonia | es_ES |
| dc.subject | biomarkers | es_ES |
| dc.subject | MR proadrenomedullin | es_ES |
| dc.subject | procalcitonin | es_ES |
| dc.subject | ferritin | es_ES |
| dc.subject | CRP | es_ES |
| dc.subject | sepsis | es_ES |
| dc.subject | virus | es_ES |
| dc.subject | ICU admission | es_ES |
| dc.title | Plasma Levels of Mid-Regional Proadrenomedullin Accurately Identify H1N1pdm09 Influenza Virus Patients with Risk of Intensive Care Admission and Mortality in the Emergency Department | es_ES |
| dc.type | journal article | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.3390/jpm12010084 | |